2024-10-31 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Analysis Report

**Company Overview:** Intuitive Surgical Inc. is a leading developer and manufacturer of robotic-assisted surgical systems and instruments. 

**1. Performance Comparison with S&P 500 (VOO):**

* **Cumulative Return (ISRG):** 373.73%
* **Cumulative Return (VOO):** 136.74%
* **Divergence:** 236.99%
* **Relative Divergence:** 81.65%

**Interpretation:** ISRG has significantly outperformed the S&P 500 over the period analyzed, exceeding VOO's return by over 236%. This performance places ISRG within the 81.65th percentile of its historical performance relative to the S&P 500.

**2. Recent Price Movement:**

* **Last Market:** 509.62
* **Closing Price:** 516.31
* **5-day Moving Average:** 512.53
* **20-day Moving Average:** 494.79
* **60-day Moving Average:** 485.38

**Interpretation:** The stock is currently trading above its 5-day, 20-day, and 60-day moving averages, suggesting a potential upward trend.

**3. Technical Indicators:**

* **RSI:** 64.85
* **PPO:** 0.44
* **Delta_Previous_Relative_Divergence:** 6.42 (+)
* **Expected Return:** 12.49%

**Interpretation:** 
* The RSI indicates the stock is in the overbought territory, suggesting a potential correction in the short term.
* The PPO is positive and above 0, indicating bullish momentum.
* The positive Delta_Previous_Relative_Divergence suggests a short-term uptrend.
* The Expected Return of 12.49% indicates a potential for significant outperformance compared to the S&P 500 over the long term.

**4. Recent Earnings and Outlook:**

| Date       | EPS    | Revenue       |
|------------|--------|----------------|
| 2024-10-18 | 1.59   | $2.04B         |
| 2024-07-19 | 1.48   | $2.01B         |
| 2024-04-19 | 1.54   | $1.89B         |
| 2023-10-20 | 1.18   | $1.74B         |
| 2023-10-18 | 1.18   | $1.74B         |

**Analysis:** ISRG has consistently demonstrated strong revenue growth and profitability over the past year. While specific earnings estimates for the most recent quarter are not provided, the trend indicates a positive trajectory.  

**5. Financial Data:**

**1) Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2024-09-30  | $2.04B   | 67.41%       |
| 2024-06-30  | $2.01B   | 68.30%       |
| 2024-03-31  | $1.89B   | 65.87%       |
| 2023-12-31  | $1.93B   | 66.24%       |
| 2023-09-30  | $1.74B   | 66.94%       |

**2) Capital and Profitability:**

| Quarter      | Equity   | ROE       |
|--------------|----------|------------|
| 2024-09-30  | $15.58B | 3.63%     |
| 2024-06-30  | $14.71B | 3.58%     |
| 2024-03-31  | $13.96B | 3.90%     |
| 2023-12-31  | $13.31B | 4.56%     |
| 2023-09-30  | $12.54B | 3.32%     |

**Analysis:** ISRG consistently exhibits a strong financial performance. The company enjoys high profit margins and robust revenue growth, demonstrating its dominance in the robotic surgery market. ROE has remained steady with a slightly declining trend, potentially suggesting the company is becoming more efficient with its capital allocation.

**6. News and Recent Issues:**

* **Latest Earnings Announcement (Shaknews, etc.):**  (Please provide the specific date of the earnings report for accurate analysis)
* **Recent Market Outlook:**  (Please provide a specific time frame for analysis)
* **Analyst Opinions and Performance Highlights:** (Please provide specific sources and dates for accurate information)

**7. Overall Analysis:**

ISRG is a strong performer with a history of outperforming the market. The stock is currently trading above its major moving averages, suggesting potential upward movement. While technical indicators suggest some overbought conditions in the short term, the long-term expected return remains high. Strong financial performance and continued dominance in the robotic surgery market contribute to the positive outlook. However, it's crucial to monitor the latest earnings reports and news for potential catalysts or risks. 
